Call for Abstract

7th International Conference on Brain and Neurological Disorders, will be organized around the theme “Explore the Latest Innovative Treatment and Prevention of Brain Injury”

Brain Injury 2018 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Brain Injury 2018

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

Brain disorders are one of the most serious health problems facing our society .Brain disorders or Brain damage includes many conditions that can affect your brain. Those conditions that are caused by illness, genetics, or brain injury.

When the brain is damaged, it can affect many different things, such as memory, sensation, and functions. The brain is susceptible to different disorders that strike at every stage of our life. They are also the most mysterious of all diseases.

There are about 10 million people in the UK living with the neurological condition which has a very significant impact on their lives. Mainly stroke, Depression dementia, headache, Brain injury and epilepsy are the neurological conditions suffered in UK. It has been estimated that the lifetime risk of developing Brain and other central nervous system cancer is 1 in 133 for men and 1 in 185 for women in the UK.

  • Track 1-1Aphasia
  • Track 1-2Brain Aneurysm
  • Track 1-3Sleep Disorders
  • Track 1-4Tuberous sclerosis
  • Track 1-5Narcolepsy
  • Track 1-6Migraine
  • Track 1-7Intracranial Hypertension
  • Track 1-8Huntington’s Disease
  • Track 1-9Guillain-Barre Syndrome
  • Track 1-10Friedreich’s Ataxia
  • Track 1-11epilepsy
  • Track 1-12Dysautonomia
  • Track 1-13Coma
  • Track 1-14Brain Tumour / Cancer
  • Track 1-15Neuro oncology

These are a group of psychiatric conditions originating in childhood that includes serious impairment in different areas.   These disorders comprise language disorders, learning disorders, motor disorders and autism spectrum disorders. One of the most common developmental disorders is mental retardation. More than one out of every 100 school children in the United States has mental retardation. Second Development disorder is the Cerebral palsy, and next autism spectrum disorders.  In definitions Attention-deficit/hyperactivity disorder is included, and the term used is neurodevelopmental disorders. 

 

  • Track 2-1Autism Spectrum Disorders
  • Track 2-2Neonatal encephalopathy
  • Track 2-3 Fragile X
  • Track 2-4Down syndrome
  • Track 2-5Reading Disorder
  • Track 2-6Separation Anxiety Disorder
  • Track 2-7Stuttering
  • Track 2-8Mathematics Disorder
  • Track 2-9Oppositional Defiant Disorder
  • Track 2-10Attention Deficit/Hyperactivity Disorder 
  • Track 2-11Lysosomal storage disease

Dementia is a chronic and higher intellectual function due to organic brain disease. Dementia is condition in which a person loses their ability to think, remember, learn, and to make decisions, and solve the problems. It may also include like personality changes and emotional problems. Some other problems like decrease in motivation emotional problems and problems with language.

Globally, dementia affected total of 46 million people in 2015. About 10% of people develop this disorder at any some point of their lives. By ages 3% of the people between the ages 65–74 have dementia, and 19% of people between the age 75 and 84 and nearly half of those over 85 years of age. In 2013 dementia was resulted in about 1.7 million deaths in 1990. As more number of people are living longer, dementia is becoming very common in population as a whole.  It is to be believed to result in economic costs of 604 billion USD per year. 

  • Track 3-1Pick Disease
  • Track 3-2Drugs for Dementia
  • Track 3-3Dementia Treatment
  • Track 3-4Dementia Therapeutics
  • Track 3-5Daignosis of Dementia
  • Track 3-6 Dementia Care Research
  • Track 3-7Agitation
  • Track 3-8neurocognitive disorder
  • Track 3-9Syphilis
  • Track 3-10Vascular dementia
  • Track 3-11Dementia clinical trials

Peripheral Neuropathy is damage or disease that affects the nerves, which may be impair sensation, movement, gland or organ function, and other aspects of health, depending on type of nerve affected. Some common causes include systemic affect which causes diseases such as diabetes, vitamin deficiency, and medication.  Peripheral neuropathy may be chronic or acute. Acute neuropathies demand for urgent diagnosis. Motor nerves, sensory nerves, or autonomic nerves may be affected.  Peripheral neuropathies may be classified according to the type of nerve involved, or by the underlying cause.

Geriatric and obese population people are at high risk for the developing peripheral neuropathy. Centers for Disease Control and Prevention stated, that the people who are diagnosed with diabetes mostly are obese. so, with the rising in geriatric population and growing prevalence of diabetes propels the demand of global market to peripheral neuropathy treatment. According to World Health Organization, the global geriatric population  increase from 524 million in 2010 to about 2 billion by the year 2050. World Health Organization stated in the year 2012 that, more than the 40 million children under the age of 5 were overweight. And it has also estimated that 10% of the world population of adult was obese in 2012. 

  • Track 4-1Diabetic Neuropathy
  • Track 4-2Auditory Neuropathy
  • Track 4-3Cranial Neuropathy
  • Track 4-4Proximal Neuropathy
  • Track 4-5Alcoholic Neuropathy
  • Track 4-6Peripheral Neuropathy
  • Track 4-7Optic Neuropathy
  • Track 4-8Ulnar Neuropathy
  • Track 4-9Autonomic Neuropathy
  • Track 4-10Focal Neuropathy

 

Neurological disorder is any disorder that belongs to nervous system. Structural, biochemical or electrical abnormalities in brain, spinal cord and other nerves can result in a range of symptoms. Some symptoms like paralysis, loss of sensation, seizures, confusion, and pain.

World Health Organization estimated in the year 2006 that neurological disorders affect one billion people worldwide.


Market of CNS disorders are categorized into three segments, psychiatry, neurology and pain drugs market.. Among these the psychiatry segment has the largest share that accounting for more than 40% next followed by neurology and pain segment. As of year 2012, world health organization said that about 50 million people are suffering from epilepsy worldwide most of them belong to developing nations.

  • Track 5-1Vascular Disorders
  • Track 5-2Structural Disorders
  • Track 5-3Functional Disorders
  • Track 5-4Autoimmune Disorders
  • Track 5-5Addiction
  • Track 5-6Migraine
  • Track 5-7Attention deficit/hyperactivity disorder (ADHD)
  • Track 5-8Meningitis
  • Track 5-9Depression

Stroke is when there is a poor blood flow to the brain that results in cell death. There are two  types of stroke 1) ischemic stroke which is defined as   lack of blood flow to the brain, 2) haemorrhagic stroke which occurs due to bleeding. These result in part of the brain not functioning properly. Symptoms like inability to move or feel on one side of the body, feeling like the world is spinning, or loss of vision. If the symptoms last in less than one or two hours then  it is known as a transient ischemic attack  also known as  mini-stroke. A haemorrhagic stroke  associated with a severe headache. The symptoms of a stroke can be permanent. 

 In 2013 about 6.9 million people had an ischemic stroke and about 3.4 million people had a haemorrhagic stroke. In 2015 about 42.4 million people who had previously had a stroke and they were still alive. In between 1990 and 2010 the number of strokes which occurred each year was decreased by 10% in the developed world and increased by approximately 10% in the developing world. After coronary artery disease, death cause by the stroke was in second place in 2015. About half of the people who have had a stroke live less than the one year.

  • Track 6-1Stroke recovery and rehabilitation
  • Track 6-2Hemorrhagic stroke
  • Track 6-3Ischemic stroke
  • Track 6-4Brain stroke Diagnosis
  • Track 6-5Brain stroke Treatment
  • Track 6-6Post-stroke Depression
  • Track 6-7Subarachnoid Hemorrhage
  • Track 6-8Brainstem stroke syndrome

Spinal cord is main pathway for the communication between the brain and the rest of the body. It is a long, and fragile, tube like structure that extends downward from base of the brain.

Mostly pinal stenosis affects the people at age of 60 and also occur in younger people born with the abnormal spinal canal. Lumbar spinal stenosis, cervical spinal stenosis and thoracic spinal stenosis are the three types of spinal stenosis. Mostly 75% of the cases of spinal stenosis occur in the lower lumbar region.

  • Track 7-1Arachnoiditis
  • Track 7-2Clinical Trials
  • Track 7-3Central Cord Syndrome
  • Track 7-4Spinal Cord Tumor
  • Track 7-5LUPUS
  • Track 7-6 Syringomyelia
  • Track 7-7Spinal Stenosis
  • Track 7-8 Spina Bifida
  • Track 7-9Arterial-venous Malformation
  • Track 7-10Rehabilitation

It is a mental disorder, or mental illness. The causes of mental disorders are unknown.  Mental disorders are explained by the combination of behaviour of the  person , or  feels, or thinks. This are associated with the particular regions or functions of the brain.

Globally Some common mental disorders include depression, that affects about 400 million, dementia which affects about 35 million,  schizophrenia, that affects about 21 million people . WHO stated that 350 million populations is suffering with depression and mental disorders and approximately 24 million populations globally is affected by schizophrenia disorder. According to the survey conducted by CPA in the year 2012, about 77% of patient population receive psychotherapy are benefited or remained generalized anxiety disorder free after the treatment. 

  • Track 8-1Anxiety and Stressor-Related Disorders
  • Track 8-2Adult Attention Deficit/Hyperactivity Disorder
  • Track 8-3Bipolar Disorder
  • Track 8-4Alcohol/Substance Dependence
  • Track 8-5Schizophrenia and Related Disorders
  • Track 8-6Personality Disorders
  • Track 8-7Substance-Related Disorders
  • Track 8-8Obsessive-Compulsive and Related Disorders
  • Track 8-9Mood Disorders
  • Track 8-10Eating Disorders
  • Track 8-11Dissociative Disorders
  • Track 8-12Major Depressive Disorder

Neuroimaging is also called as brain imaging which includes various techniques to  image the morphology, functioning of the nervous system. It is a new discipline within medical knowledge.

Neuroradiology is a subspecialty of radiology that focusing on the diagnosis and characterization of abnormalities of the central and peripheral nervous system, spine and head and neck using neuroimaging techniques. It includes computed tomography (CT) and magnetic resonance imaging.

During 2066-2015 as per global report 582 patients were hospitalized with neurological disorders and the ratio of the patients having neuro-CTs raised by 86% to 88%,  neuro-MRs by 79%-93%,  and requirement of  ICU care increased  17% to 26%. 

  • Track 9-1Computed axial tomography
  • Track 9-2Diffuse optical imaging
  • Track 9-3Positron emission tomography
  • Track 9-4Magnetic resonance imaging
  • Track 9-5Single-photon emission computed tomography
  • Track 9-6Event-related optical signal
  • Track 9-7Functional neuroimaging
  • Track 9-8Medical imaging

Brain mapping is a technique or method which is used for the study of the structure and functions of different parts of the brain. Brain mapping is used for recording of brain wave activities. Brain mapping helps for surgeons in identifying brain areas which is responsible for critical functions of the body like locomotion, vision, sensation, and speech. Brain mapping helps in detection of various abnormalities such as tumours, seizures (partial, incomplete, complete) toxic injuries, Alzheimer disorders, infections. Brain mapping also helps in identifying the external environment, physical injuries. It is done by stimulation of certain brain areas that which perform language, motor, sensory, and visual functions. Brain-mapping instruments are computed tomography, positron emission tomography, electroencephalography, near-infrared spectroscopy, magneto encephalography, and functional magnetic resonance imaging. These techniques help in measuring cerebral blood flow, metabolism, and structural integrity of the brain. It is performed in two ways two-stage procedures and directly during surgery. Brain mapping, performed during surgery, is known as intraoperative brain mapping. The brain mapping procedure time depends upon targeted brain tissues for surgery and locations of surgery. 

  • Track 10-1Structural magnetic resonance imaging 
  • Track 10-2Diffusion tensor-MRI 
  • Track 10-3Electroencephalography 
  • Track 10-4Transcranial magnetic stimulation 
  • Track 10-5Statistical parametric mapping
  • Track 10-6Visual processing and image enhancement
  • Track 10-7Cranial ultrasound

Neurosurgery is a highly specialized medical field which focused on surgical treatment of brain and spine disorders.  It is a complex surgical procedure which involves diagnosis, therapy, and rehabilitation of disorders affecting any part of the nervous system. The devices which are used to perform neurosurgeries are neurosurgical devices. Which are used to perform the surgeries like oncological neurosurgery, endovascular neurosurgery, and stereotactic neurosurgery. These surgeries are performed to treat neurological disorders like tumours, trauma, and brain injuries
 

  • Track 11-1Neuroplasticity 
  • Track 11-2Spine Surgery
  • Track 11-3Minimally invasive surgery
  • Track 11-4Functional neurosurgery
  • Track 11-5Peripheral nerve injury
  • Track 11-6Trigeminal neuralgia and nerve compression syndromes
  • Track 11-7General neurosurgery
  • Track 11-8Epilepsy neurosurgery
  • Track 11-9Spinal neurosurgery
  • Track 11-10Peripheral nerve transfers for cervical spine injury 
  • Track 11-11Cortical spreading depression
  • Track 11-12 Glioblastoma residuals post resection
  • Track 11-13Trigeminal Neuralgia

Neuropharmacology is the branch that deals with the study how the drugs affect the cell function in the central nervous system, and the neural mechanisms by which they influence behavioural changes.  Two main branches of neuropharmacology which includes 1) behavioural neuropharmacology and 2) molecular neuropharmacology. 1) Behavioural neuropharmacology mainly deals with how drug dependence and addiction affect the human brain. 2) Molecular neuropharmacology is the study about the neurons and their neurochemical interactions. Both of these fields are closely connected, since both are concerned with the interactions. By these interactions, researchers are developing drugs to treat different neurological disorders, such as  pain, neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease, psychological disorders, like  addiction, and many others.

  • Track 12-1Clinical neuropharmacology and therapeutics
  • Track 12-2Clinical neuropharmacology of hypothalamic releasing factors
  • Track 12-3Behavioral neuropharmacology
  • Track 12-4Molecular neuropharmacology
  • Track 12-5Behavioral neuropharmacology
  • Track 12-6Neurochemical interactions
  • Track 12-7Neuropsychopharmacology
  • Track 12-8Preclinical psychopharmacology

Neuropathology is a branch which deals with the study of diseases of the nervous system, and typically that includes the laboratory analysis of tissue samples for personalized diagnosis and forensic investigations. Neuropathologists who make these diagnoses and conduct research in this field, areas which includes are brain tumours, Alzheimer disease and neurodegenerative disorders, stroke and cerebrovascular disorders, cerebral palsy and developmental disorders of the brain.

  • Track 13-1Dementia
  • Track 13-2Developmental neuropathology
  • Track 13-3Surgical neuropathology
  • Track 13-4Neurofibrillary Tangles
  • Track 13-5Schizophrenia
  • Track 13-6Brain Injuries
  • Track 13-7Encephalopathies
  • Track 13-8Neoplasms
  • Track 13-9Nerve Degeneration
  • Track 13-10Cerebellar neuropathology

Procedures that have been proving to be advantageous in nervous disease therapy like regenerative therapies, gene therapy, neural stem cell therapy, transracial direct current stimulation therapy etc.

  • Track 14-1Neurotherapeutics Discovery and Development Process
  • Track 14-2Formulation and Non-Clinical Proof-of-Concept
  • Track 14-3Preclinical Proof-of-Concept/Target Engagement Studies
  • Track 14-4Experimental Medicine and Biomarkers

Neurodegenerative disorder is the progressive loss of structure or function of the neurons, including the death of the neurons. Some of the neurodegenerative diseases are Multiple sclerosis, Parkinson's, Alzheimer's, Motor neurone diseases, and Huntington's occur as a result of neurodegenerative processes. Such diseases are mostly incurable, resulting in progressive degeneration or death of the neuron cells. Neurodegeneration can found in the many different levels of neuronal circuitry ranging from the molecular to systemic.

Based on regions, global neurodegenerative disease market is segmented into the seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa. Global market for neurodegenerative disease is expected to grow by a CAGR are of around 5%. Asia Pacific is expected to witness the highest growth due to the large population base over the forecast years.

  • Track 15-1Multiple Sclerosis
  • Track 15-2Creutzfeld-Jakob disease
  • Track 15-3Migraine and chronic pain 
  • Track 15-4Epilepsy
  • Track 15-5Rare neurological diseases
  • Track 15-6Motor Neurone Diseases
  • Track 15-7Spinocerebellar Ataxia 
  • Track 15-8Spinal muscular atrophy